|
1
|
El-Serag HB and Rudolph KL: Hepatocellular
carcinoma: epidemiology and molecular carcinogenesis.
Gastroenterology. 132:2557–2576. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Aljiffry M, Walsh MJ and Molinari M:
Advances in diagnosis, treatment and palliation of
cholangiocarcinoma: 1990–2009. World J Gastroenterol. 15:4240–4262.
2009.PubMed/NCBI
|
|
3
|
Deoliveira ML, Schulick RD, Nimura Y,
Rosen C, Gores G, Neuhaus P and Clavien PA: New staging system and
a registry for perihilar cholangiocarcinoma. Hepatology.
53:1363–1371. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Khan SA, Thomas HC, Davidson BR and
Taylor-Robinson SD: Cholangiocarcinoma. Lancet. 366:1303–1314.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Sempoux C, Jibara G, Ward SC, Fan C, Qin
L, Roayaie S, Fiel MI, Schwartz M and Thung SN: Intrahepatic
cholangiocarcinoma: new insights in pathology. Semin Liver Dis.
31:49–60. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Mueller MM and Fusenig NE: Friends or foes
- bipolar effects of the tumour stroma in cancer. Nat Rev Cancer.
4:839–849. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kalluri R and Zeisberg M: Fibroblasts in
cancer. Nat Rev Cancer. 6:392–401. 2006. View Article : Google Scholar
|
|
8
|
Sirica AE: The role of cancer-associated
myofibroblasts in intrahepatic cholangiocarcinoma. Nat Rev
Gastroenterol Hepatol. 9:44–54. 2011. View Article : Google Scholar
|
|
9
|
Fabris L, Cadamuro M, Moserle L, Dziura J,
Cong X, Sambado L, Nardo G, Sonzogni A, Colledan M, Furlanetto A,
Bassi N, Massani M, Cillo U, Mescoli C, Indraccolo S, Rugge M,
Okolicsanyi L and Strazzabosco M: Nuclear expression of S100A4
calcium-binding protein increases cholangiocarcinoma invasiveness
and metastasisation. Hepatology. 54:890–899. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Holt AP, Haughton EL, Lalor PF, Filer A,
Buckley CD and Adams DH: Liver myofibroblasts regulate infiltration
and positioning of lymphocytes in human liver. Gastroenterology.
136:705–714. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Folkman J: Fundamental concepts of the
angiogenic process. Curr Mol Med. 3:643–651. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Albini A and Sporn MB: The tumour
microenvironment as a target for chemoprevention. Nat Rev Cancer.
7:139–147. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
13
|
Garin-Chesa P, Old LJ and Rettig WJ: Cell
surface glycoprotein of reactive stromal fibroblasts as a potential
antibody target in human epithelial cancers. Proc Natl Acad Sci
USA. 87:7235–7239. 1990. View Article : Google Scholar
|
|
14
|
Xing F, Saidou J and Watabe K: Cancer
associated fibroblasts (CAFs) in tumor microenvironment. Front
Biosci. 15:166–179. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
15
|
Sirica AE, Campbell DJ and Dumur CI:
Cancer-associated fibroblasts in intrahepatic cholangiocarcinoma.
Curr Opin Gastroenterol. 27:276–284. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Nishihara Y, Aishima S, Hayashi A, Iguchi
T, Fujita N, Taketomi A, Honda H and Tsuneyoshi M: CD10+
fibroblasts are more involved in the progression of
hilar/extrahepatic cholangiocarcinoma than of peripheral
intrahepatic cholangiocarcinoma. Histopathology. 55:423–431.
2009.
|
|
17
|
Chuaysri C, Thuwajit P and Paupairoj A:
Alpha-smooth muscle actin-positive fibroblasts promote biliary cell
proliferation and correlate with poor survival in
cholangiocarcinoma. Oncol Rep. 21:957–969. 2009.PubMed/NCBI
|
|
18
|
Utispan K, Thuwajit P and Abiko Y: Gene
expression profiling of cholangiocarcinoma-derived fibroblasts
reveals alterations related to tumor progression and indicates
periostin as a poor prognostic marker. Mol Cancer. 9:132010.
View Article : Google Scholar
|
|
19
|
Campbell DJW, Dumur CI, Lamour NF, DeWitt
JL and Sirica AE: Novel organotypic culture model of
cholangiocarcinoma progression. Hepatol Res. 42:1119–1130. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lim JH: Cholangiocarcinoma: morphologic
classification according to growth pattern and imaging findings.
AJR Am J Roentgenol. 181:819–827. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Fabris L, Strazzabosco M, Crosby HA,
Ballardini G, Hubscher SG, Kelly DA, Neuberger JM, Strain AJ and
Joplin R: Characterization and isolation of ductular cells
coexpressing neural cell adhesion molecule and Bcl-2 from primary
cholangiopathies and ductal plate malformations. Am J Pathol.
156:1599–1612. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Auth MK, Woitaschek D, Beste M, Schreiter
T, Kim HS, Oppermann E, Joplin RE, Baumann U, Hilgard P, Nadalin S,
Markus BH and Blaheta RA: Preservation of the synthetic and
metabolic capacity of isolated human hepatocytes by coculture with
human biliary epithelial cells. Liver Transpl. 11:410–419. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Cannito S, Novo E, Compagnone A, Valfrè di
Bonzo L, Busletta C, Zamara E, Paternostro C, Povero D, Bandino A,
Bozzo F, Cravanzola C, Bravoco V, Colombatto S and Parola M: Redox
mechanisms switch on hypoxia-dependent epithelial-mesenchymal
transition in cancer cells. Carcinogenesis. 29:2267–2278. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Bateman AC and Hübscher SG: Cytokeratin
expression as an aid to diagnosis in medical liver biopsies.
Histopathology. 56:415–425. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Mork C, van Deurs B and Petersen OW:
Regulation of vimentin expression in cultured human mammary
epithelial cells. Differentiation. 43:146–156. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Tomasek JJ, Gabbiani G, Hinz B, Chaponnier
C and Brown RA: Myofibroblasts and mechanoregulation of connective
tissue remodelling. Nat Rev Mol Cell Biol. 3:349–363. 2002.
View Article : Google Scholar : PubMed/NCBI
|
